<DOC>
	<DOCNO>NCT02574390</DOCNO>
	<brief_summary>Creation large repository induce pluripotent stem cell ( iPSC ) , bio-fluid sample ( blood spinal fluid ( optional ) ) , cell line ALS gene identification . This combine carefully collect measure pattern symptom people ALS change time .</brief_summary>
	<brief_title>Answer ALS : Individualized Initiative ALS Discovery</brief_title>
	<detailed_description>Patients 5 study visit ; screen , 3 , 6 , 9 12 month . There one year post-participation follow-up period , receive email phone call interview every 3 month . During first year , sample collect , breathe , muscle strength , spasticity , general function cognitive behavior assess</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<criteria>Participants familial sporadic ALS diagnose possible , laboratorysupported probable , probable definite accord World Federation Neurology ( WFN ) El Escorial criterion , Primary Lateral Sclerosis Flail Arm ALS , Progressive Muscular Atrophy , Monomelic Amyotrophy , Motor Neuron Disease , Asymptomatic ALS Gene Carriers Participants age 18100 , inclusive . Participants SpinalBulbar Muscular Atrophy Known diagnosis HIV/AIDS , Hepatitis B , Hepatitis C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>ALS</keyword>
	<keyword>stem cell</keyword>
	<keyword>biomarker</keyword>
	<keyword>disease progression</keyword>
</DOC>